T1	PROC 45 76	Estudio de eficacia y seguridad
T2	CHEM 80 89	ianalumab
T3	LIVB 93 102	pacientes
#1	AnnotatorNotes T3	C0030705; Patients; Patient or Disabled Group
T4	PROC 115 123	tratados
T5	DISO 128 156	anemia hemolítica autoinmune
#2	AnnotatorNotes T5	C0002880; Autoimmune hemolytic anemia; Disease or Syndrome
T6	CHEM 161 182	anticuerpos calientes
#3	AnnotatorNotes T6	C0301842; Warm antibody; Amino Acid, Peptide, or Protein · Immunologic Factor
T7	PROC 203 250	Estudio de fase III, aleatorizado y doble ciego
T8	PROC 264 298	evalúan la eficacia y la seguridad
T9	CHEM 302 311	ianalumab
T10	CHEM 313 319	VAY736
T11	PROC 330 337	placebo
#4	AnnotatorNotes T11	C0032042; Placebos; Therapeutic or Preventive Procedure
T12	LIVB 341 350	pacientes
#5	AnnotatorNotes T12	C0030705; Patients; Patient or Disabled Group
T13	DISO 355 409	anemia hemolítica autoinmune por anticuerpos calientes
T14	DISO 411 416	AHAIc
T15	PROC 466 477	tratamiento
#6	AnnotatorNotes T15	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T16	DISO 500 554	Anemia hemolítica autoinmune por anticuerpos calientes
T17	DISO 556 561	AHAIc
T18	Age 591 598	18 años
T19	Age 607 612	o más
T20	PROC 636 650	consentimiento
T21	LIVB 654 667	Participantes
T22	DISO 672 677	AHAIc
T23	PROC 759 790	prueba de antiglobulina directa
T24	PROC 791 832	[PAD] específica para anti-IgG o anti-IgA
T25	DISO 891 898	recaído
T26	PROC 932 943	tratamiento
#7	AnnotatorNotes T26	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T27	LIVB 959 968	pacientes
#8	AnnotatorNotes T27	C0030705; Patients; Patient or Disabled Group
T28	DISO 986 997	dependencia
#9	AnnotatorNotes T28	C0439857; Dependence; Mental or Behavioral Dysfunction | C1510472; Drug Dependence; Mental or Behavioral Dysfunction
T29	DISO 1000 1012	intolerancia
T30	CHEM 1019 1029	esteroides
#10	AnnotatorNotes T30	C0038317; Steroids; Organic Chemical · Pharmacologic Substance
T31	PROC 1033 1061	Concentración de hemoglobina
T32	DISO 1115 1123	síntomas
#11	AnnotatorNotes T32	C1457887; Symptoms; Sign or Symptom
T33	DISO 1144 1150	anemia
#12	AnnotatorNotes T33	C0002871; Anemia; Disease or Syndrome
T34	PROC 1167 1189	tratamiento de soporte
T35	Duration 1215 1233	al menos 4 semanas
T36	PROC 1246 1260	aleatorización
#13	AnnotatorNotes T36	C0034656; Randomization; Research Activity
T37	Speculated 1268 1290	criterios de inclusión
T38	PROC 1305 1314	protocolo
#14	AnnotatorNotes T38	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T39	Spec_cue 1315 1321	pueden
T40	LIVB 1358 1367	Pacientes
#15	AnnotatorNotes T40	C0030705; Patients; Patient or Disabled Group
T41	DISO 1372 1377	AHAIc
T42	DISO 1391 1414	enfermedad hematológica
#16	AnnotatorNotes T42	C0018939; Hematological Disease; Disease or Syndrome
T43	ANAT 1431 1442	médula ósea
#17	AnnotatorNotes T43	C0005953; Bone Marrow; Tissue
T44	DISO 1457 1460	LLC
#18	AnnotatorNotes T44	C0023434; Chronic Lymphocytic Leukemia; Neoplastic Process
T45	DISO 1469 1492	enfermedad inmunológica
#19	AnnotatorNotes T45	C0021053; Immune System Diseases; Disease or Syndrome
T46	PROC 1506 1535	tratamientos inmunosupresores
T47	Contraindicated 1506 1535	tratamientos inmunosupresores
T48	Neg_cue 1540 1542	no
T49	Negated 1549 1559	permitidos
T50	DISO 1608 1612	AHAI
#20	AnnotatorNotes T50	C0002880; Autoimmune hemolytic anemia; Disease or Syndrome
T51	DISO 1618 1629	anticuerpos
T52	DISO 1647 1664	síndrome de Evans
#21	AnnotatorNotes T52	C0272126; Evans syndrome; Disease or Syndrome
T53	DISO 1673 1683	citopenias
#22	AnnotatorNotes T53	C0010828; Cytopenia; Pathologic Function
T54	PROC 1703 1736	terapia de depleción de células B
T55	CHEM 1743 1752	rituximab
#23	AnnotatorNotes T55	C0393022; rituximab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T56	Duration 1762 1776	las 12 semanas
T57	PROC 1793 1807	aleatorización
#24	AnnotatorNotes T57	C0034656; Randomization; Research Activity
T58	PROC 1811 1822	Neutrófilos
T59	PROC 1836 1853	Creatinina sérica
#25	AnnotatorNotes T59	C0201976; Creatinine measurement, serum (procedure); Laboratory Procedure
T60	DISO 1909 1941	Infecciones víricas, bacterianas
T61	DISO 1950 1961	infecciones
#26	AnnotatorNotes T61	C0009450; Communicable Diseases; Disease or Syndrome | C3714514; Infection; Pathologic Function
T62	DISO 1983 1995	tuberculosis
#27	AnnotatorNotes T62	C0041296; Tuberculosis; Disease or Syndrome | C0041327; Tuberculosis, Pulmonary; Disease or Syndrome
T63	LIVB 1998 2008	SARS-CoV-2
#28	AnnotatorNotes T63	C5203676; SARS-CoV-2; Virus
T64	PROC 2024 2045	tratamiento sistémico
T65	Route 2036 2045	sistémico
T66	DISO 2095 2106	infecciones
#29	AnnotatorNotes T66	C0009450; Communicable Diseases; Disease or Syndrome | C3714514; Infection; Pathologic Function
T67	DISO 2160 2183	infecciones bacterianas
#30	AnnotatorNotes T67	C0004623; Bacterial Infections; Disease or Syndrome
T68	LIVB 2188 2198	organismos
#31	AnnotatorNotes T68	C0029235; Organism; Organism
T69	DISO 2216 2227	Positividad
T70	DISO 2233 2256	virus de la hepatitis C
T71	PROC 2258 2298	antígeno de superficie de la hepatitis B
#32	AnnotatorNotes T71	C0201477; Hepatitis B surface antigen measurement; Laboratory Procedure
T72	PROC 2300 2305	HBsAg
#33	AnnotatorNotes T72	C0201477; Hepatitis B surface antigen measurement; Laboratory Procedure
T73	PROC 2309 2348	anticuerpo del núcleo de la hepatitis B
T74	PROC 2350 2355	HBcAb
T75	DISO 2386 2425	inmunodeficiencia primaria o secundaria
T76	PROC 2445 2449	test
#34	AnnotatorNotes T76	C0022885; Laboratory Procedures; Laboratory Procedure
T77	DISO 2462 2498	virus de la inmunodeficiencia humana
T78	DISO 2500 2503	HIV
T79	CHEM 2508 2533	Vacunas vivas o atenuadas
T80	Duration 2542 2555	las 4 semanas
T81	PROC 2572 2586	aleatorización
#35	AnnotatorNotes T81	C0034656; Randomization; Research Activity
T82	PROC 2602 2615	esplenectomía
#36	AnnotatorNotes T82	C0037995; Splenectomy; Therapeutic or Preventive Procedure
T83	Speculated 2602 2615	esplenectomía
T84	Speculated 2616 2621	Otros
T85	Speculated 2622 2644	criterios de exclusión
T86	PROC 2659 2668	protocolo
#37	AnnotatorNotes T86	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T87	Spec_cue 2669 2675	pueden
